These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 8675285)
21. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371 [TBL] [Abstract][Full Text] [Related]
22. Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis. Otsuka T; Kirkham C; Johnson A; Jones MM; Murphy TF Infect Immun; 2014 Aug; 82(8):3503-12. PubMed ID: 24914218 [TBL] [Abstract][Full Text] [Related]
23. Immunoinformatics Identifies a Lactoferrin Binding Protein A Peptide as a Promising Vaccine With a Global Protective Prospective Against Moraxella catarrhalis. Yassin GM; Amin MA; Attia AS J Infect Dis; 2016 Jun; 213(12):1938-45. PubMed ID: 26908723 [TBL] [Abstract][Full Text] [Related]
24. Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen. Yang M; Johnson A; Murphy TF Infect Immun; 2011 Feb; 79(2):846-57. PubMed ID: 21134967 [TBL] [Abstract][Full Text] [Related]
25. Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis. Murphy TF; Kirkham C; DeNardin E; Sethi S Infect Immun; 1999 Sep; 67(9):4578-85. PubMed ID: 10456903 [TBL] [Abstract][Full Text] [Related]
27. Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine. Jiao X; Hirano T; Hou Y; Gu XX Infect Immun; 2002 Nov; 70(11):5982-9. PubMed ID: 12379673 [TBL] [Abstract][Full Text] [Related]
28. The immunogenicity of the liposome-associated outer membrane proteins (OMPs) of Moraxella catarrhalis. Augustyniak D; Mleczko J; Gutowicz J Cell Mol Biol Lett; 2010; 15(1):70-89. PubMed ID: 19851720 [TBL] [Abstract][Full Text] [Related]
29. Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2. Shaffer TL; Balder R; Buskirk SW; Hogan RJ; Lafontaine ER PLoS One; 2013; 8(7):e67881. PubMed ID: 23844117 [TBL] [Abstract][Full Text] [Related]
30. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E. Aebi C; Lafontaine ER; Cope LD; Latimer JL; Lumbley SL; McCracken GH; Hansen EJ Infect Immun; 1998 Jul; 66(7):3113-9. PubMed ID: 9632574 [TBL] [Abstract][Full Text] [Related]
31. Intranasal immunization of the combined lipooligosaccharide conjugates protects mice from the challenges with three serotypes of Moraxella catarrhalis. Ren D; Xie H; Zhang W; Hassan F; Petralia RS; Yu S; Lim DJ; Gu XX PLoS One; 2011; 6(12):e29553. PubMed ID: 22216312 [TBL] [Abstract][Full Text] [Related]
32. Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis. Ruckdeschel EA; Brauer AL; Johnson A; Murphy TF Vaccine; 2009 Nov; 27(50):7065-72. PubMed ID: 19786139 [TBL] [Abstract][Full Text] [Related]
33. Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay. Helminen ME; Beach R; Maciver I; Jarosik G; Hansen EJ; Leinonen M Clin Diagn Lab Immunol; 1995 Jan; 2(1):35-9. PubMed ID: 7719910 [TBL] [Abstract][Full Text] [Related]
34. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children. Chen D; Barniak V; VanDerMeid KR; McMichael JC Infect Immun; 1999 Mar; 67(3):1310-6. PubMed ID: 10024576 [TBL] [Abstract][Full Text] [Related]
35. Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin. Campagnari AA; Ducey TF; Rebmann CA Infect Immun; 1996 Sep; 64(9):3920-4. PubMed ID: 8751951 [TBL] [Abstract][Full Text] [Related]
36. Effect of immunization of pulmonary clearance of Moraxella catarrhalis in an animal model. Maciver I; Unhanand M; McCracken GH; Hansen EJ J Infect Dis; 1993 Aug; 168(2):469-72. PubMed ID: 8335988 [TBL] [Abstract][Full Text] [Related]
37. The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children. Meier PS; Troller R; Grivea IN; Syrogiannopoulos GA; Aebi C Vaccine; 2002 Mar; 20(13-14):1754-60. PubMed ID: 11906762 [TBL] [Abstract][Full Text] [Related]
38. Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model. Becker PD; Bertot GM; Souss D; Ebensen T; Guzmán CA; Grinstein S Infect Immun; 2007 Apr; 75(4):1778-84. PubMed ID: 17101651 [TBL] [Abstract][Full Text] [Related]
39. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Sarwar J; Campagnari AA; Kirkham C; Murphy TF Infect Immun; 1992 Mar; 60(3):804-9. PubMed ID: 1371769 [TBL] [Abstract][Full Text] [Related]
40. Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis. Adlowitz DG; Sethi S; Cullen P; Adler B; Murphy TF Infect Immun; 2005 Oct; 73(10):6601-7. PubMed ID: 16177336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]